EBITDA Summary of Medistim ASA

Medistim ASA's latest annual EBITDA in 2023 was 155.09 Million NOK , down -8.47% from previous year.
Medistim ASA's latest quarterly EBITDA in 2024 Q3 was 35.82 Million NOK , down -20.76% from previous quarter.
Medistim ASA reported an annual EBITDA of 163.77 Million NOK in 2022, up 23.09% from previous year.
Medistim ASA reported an annual EBITDA of 132.02 Million NOK in 2021, up 19.83% from previous year.
Medistim ASA reported a quarterly EBITDA of 35.82 Million NOK for 2024 Q3, down -20.76% from previous quarter.
Medistim ASA reported a quarterly EBITDA of 38.4 Million NOK for 2024 Q1, up 5.86% from previous quarter.

Annual EBITDA Chart of Medistim ASA (2023 - 2004)

Historical Annual EBITDA of Medistim ASA (2023 - 2004)

Year	EBITDA	EBITDA Growth
2023	155.09 Million NOK	-8.47%
2022	163.77 Million NOK	23.09%
2021	132.02 Million NOK	19.83%
2020	108.27 Million NOK	4.94%
2019	109.74 Million NOK	25.33%
2018	86.33 Million NOK	8.75%
2017	80.38 Million NOK	22.46%
2016	65.6 Million NOK	-9.27%
2015	66.81 Million NOK	34.12%
2014	53.91 Million NOK	18.4%
2013	45.53 Million NOK	-5.01%
2012	47.93 Million NOK	41.71%
2011	27.57 Million NOK	-12.5%
2010	29.83 Million NOK	-24.86%
2009	51.44 Million NOK	40.42%
2008	26.76 Million NOK	37.84%
2007	23.88 Million NOK	-73.32%
2006	99.62 Million NOK	22.14%
2005	81.56 Million NOK	7.09%
2004	76.16 Million NOK	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	47.68 Million NOK	17.71%
2024 Q3	35.82 Million NOK	-20.76%
2024 Q1	38.4 Million NOK	5.86%
2023 FY	- NOK	-8.47%
2023 Q3	38.92 Million NOK	-19.85%
2023 Q4	29.29 Million NOK	-24.72%
2023 Q1	46.78 Million NOK	42.49%
2023 Q2	48.56 Million NOK	3.79%
2022 Q1	40.45 Million NOK	138.68%
2022 Q3	44.55 Million NOK	-13.67%
2022 Q4	32.83 Million NOK	-26.31%
2022 FY	- NOK	23.09%
2022 Q2	51.61 Million NOK	27.57%
2021 Q4	16.95 Million NOK	-50.5%
2021 FY	- NOK	19.83%
2021 Q2	49.56 Million NOK	34.24%
2021 Q1	36.92 Million NOK	207.85%
2021 Q3	34.24 Million NOK	-30.91%
2020 FY	- NOK	4.94%
2020 Q1	36.91 Million NOK	67.05%
2020 Q2	34.68 Million NOK	-6.05%
2020 Q3	31.3 Million NOK	-9.74%
2020 Q4	11.99 Million NOK	-61.69%
2019 Q1	24.6 Million NOK	-11.23%
2019 Q2	35.88 Million NOK	45.85%
2019 FY	- NOK	25.33%
2019 Q4	22.09 Million NOK	-17.83%
2019 Q3	26.89 Million NOK	-25.06%
2018 Q4	27.72 Million NOK	45.86%
2018 Q2	22.67 Million NOK	26.25%
2018 Q1	17.96 Million NOK	11.03%
2018 FY	- NOK	8.75%
2018 Q3	19 Million NOK	-16.19%
2017 Q4	16.17 Million NOK	-33.37%
2017 Q2	18.6 Million NOK	-12.57%
2017 FY	- NOK	22.46%
2017 Q3	24.28 Million NOK	30.54%
2017 Q1	21.27 Million NOK	244.2%
2016 Q1	16.49 Million NOK	55.9%
2016 FY	- NOK	-9.27%
2016 Q4	6.18 Million NOK	-68.36%
2016 Q3	19.53 Million NOK	-16.48%
2016 Q2	23.39 Million NOK	41.77%
2015 Q1	20.67 Million NOK	52.6%
2015 FY	- NOK	34.12%
2015 Q4	10.58 Million NOK	-40.7%
2015 Q3	17.84 Million NOK	-12.79%
2015 Q2	20.46 Million NOK	-1.01%
2014 FY	- NOK	18.4%
2014 Q4	13.54 Million NOK	-2.02%
2014 Q3	13.82 Million NOK	-14.51%
2014 Q2	16.17 Million NOK	55.96%
2014 Q1	10.36 Million NOK	25.82%
2013 Q4	8.24 Million NOK	-19.68%
2013 Q3	10.26 Million NOK	-41.76%
2013 FY	- NOK	-5.01%
2013 Q2	17.61 Million NOK	93.58%
2013 Q1	9.1 Million NOK	243.82%
2012 Q2	13.72 Million NOK	22.09%
2012 Q3	20.32 Million NOK	48.15%
2012 Q4	2.64 Million NOK	-86.98%
2012 FY	- NOK	41.71%
2012 Q1	11.23 Million NOK	47.36%
2011 Q4	7.62 Million NOK	14.76%
2011 FY	- NOK	-12.5%
2011 Q2	10.81 Million NOK	23.64%
2011 Q3	6.64 Million NOK	-38.53%
2011 Q1	8.74 Million NOK	-4.66%
2010 FY	- NOK	-24.86%
2010 Q4	9.17 Million NOK	3.42%
2010 Q3	8.86 Million NOK	-34.99%
2010 Q2	13.64 Million NOK	95.5%
2010 Q1	6.97 Million NOK	52.9%
2009 Q2	15.16 Million NOK	-9.87%
2009 Q1	16.82 Million NOK	0.0%
2009 FY	- NOK	40.42%
2009 Q4	4.56 Million NOK	-69.37%
2009 Q3	14.89 Million NOK	-1.73%
2008 FY	- NOK	37.84%
2007 FY	- NOK	-73.32%
2006 FY	- NOK	22.14%
2005 FY	- NOK	7.09%
2004 FY	- NOK	0.0%

Peer EBITDA Comparison of Medistim ASA

Name	EBITDA	EBITDA Difference
Gentian Diagnostics ASA	-3.92 Million NOK	4055.598%
Lifecare AS	-32.09 Million NOK	583.25%

Global Stocks Search

Medistim ASA (MEDI.OL)

EBITDA Summary of Medistim ASA

Annual EBITDA Chart of Medistim ASA (2023 - 2004)

Historical Annual EBITDA of Medistim ASA (2023 - 2004)

Peer EBITDA Comparison of Medistim ASA